Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

198.47
+5.132.65%
Post-market: 199.030.5605+0.28%19:59 EDT
Volume:6.43M
Turnover:1.27B
Market Cap:351.09B
PE:84.82
High:198.98
Open:195.17
Low:194.63
Close:193.34
Loading ...

Gilead Sciences Down 3%, Amgen Down 2.9%, Pfizer Down 2.7%

THOMSON REUTERS
·
09 Apr

Drugmakers Down Premarket After Trump Threatens Tariffs on Sector

THOMSON REUTERS
·
09 Apr

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

Dow Jones
·
09 Apr

AbbVie Hold Rating: Balancing Strong Immunology Growth with Challenges in Aesthetics, Neuroscience, and Oncology

TIPRANKS
·
09 Apr

AbbVie Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
09 Apr

Biopharma Shakeup: Goldman Boosts J&J, Eli Lilly While Flagging Risks at Pfizer and AbbVie

GuruFocus
·
09 Apr

AbbVie Coverage Assumed by Goldman Sachs at Neutral

Dow Jones
·
09 Apr

AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell Arteritis

Zacks
·
08 Apr

Goldman turns cautious on major pharma names, sees select upside at Eli Lilly

Investing.com
·
08 Apr

Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?

Zacks
·
08 Apr

AbbVie Gets Expanded Europe OK for Rinvoq in Giant Cell Arteritis

Dow Jones
·
08 Apr

AbbVie assumed with a Neutral at Goldman Sachs

TIPRANKS
·
08 Apr

AbbVie Secures European Marketing Clearance for Giant Cell Arteritis Treatment Rinvoq

MT Newswires Live
·
08 Apr

BRIEF-Abbvie Announces European Commission Approval Of Rinvoq For Adults

Reuters
·
08 Apr

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis

PR Newswire
·
08 Apr

AbbVie (NYSE:ABBV) Showcases Cancer Treatment Advancements at AACR Annual Meeting

Simply Wall St.
·
08 Apr

Tariffs Pose $46 Billion Risk to Pharmaceutical Industry -- Analysis

Dow Jones
·
05 Apr

Shares of Some U.S. Drugmakers Down After Trump Says Pharmaceutical Sector Is 'Under Review' for Tariffs

THOMSON REUTERS
·
04 Apr

BUZZ-US drugmakers fall after Trump's new tariff warnings

Reuters
·
04 Apr

AbbVie (ABBV) Stock Moves -1.73%: What You Should Know

Zacks
·
04 Apr